Inflammatory bowel disease: Moving toward a stem cell-based therapy

doi:10.3748/wjg.14.4616

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4022)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

381

HTML

3365

Figures (1-2)

276

Sum=4022

Aug 7, 2008 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (50)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 7, 2008; 14(29): 4616-4626
Published online Aug 7, 2008. doi: 10.3748/wjg.14.4616

Full Size Figure Download Figure

Figure 2 Contribution of transplanted HSCs and MSCs to the immune compartment and to intestinal lineages. HSCs are able to restore the immune system to a naive state. MSCs contribute via direct differentiation to mesenchymal and non-mesenchymal lineages, exert trophic functions and modulate in a suppressive fashion the immune response.

Citation: Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. Inflammatory bowel disease: Moving toward a stem cell-based therapy. World J Gastroenterol 2008; 14(29): 4616-4626
URL: https://www.wjgnet.com/1007-9327/full/v14/i29/4616.htm
DOI: https://dx.doi.org/10.3748/wjg.14.4616